Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abdominal, Acknowledgment, Africa, albeit, Alpha, AMITIZA, androgen, black, blinded, box, bromide, Carlo, chemotherapeutic, cholesterol, chromosomal, climate, commonly, confirmed, crowley, currency, database, deferral, Deposit, diminishing, dislocated, dispensed, displacing, DNA, Dutch, economy, encouraged, enzyme, escalation, exit, explained, extreme, Facet, fall, GSK, heavily, hedged, hedging, hereof, identical, impossible, inactive, inflammatory, ingredient, interferon, Japanese, lawmaking, laxative, learn, light, lubiprostone, maraviroc, mechanism, modest, Monte, Moody, Mundipharma, Nektar, neovasculature, newest, noncash, Ono, Osaka, periphery, peter, Poor, portal, predominantly, publicly, pursuit, reacquired, reclassification, reclassified, redeployed, resection, reside, ribavirin, satisfaction, Seroconversion, signature, simulation, sNDA, stability, standstill, strictly, student, Sucampo, suppression, Takeda, TARGIN, temporarily, territory, topic, transparency, transplantation, turmoil, turn, turning, unadjusted, unclear, unfavorable, upper, Vax, Venezuela, Venezuelan, volume, weekly, widespread
Removed:
adjuvant, administering, affiliate, affinity, ahead, antiviral, approvable, Assumption, avoided, bioMerieux, biopharma, called, Cambridge, caption, coating, commencing, commitment, consented, consequentially, constitute, consultant, controlling, Counsel, covering, cumulatively, cured, deducted, deduction, deploying, designation, destroy, disagreement, discharged, discontinue, discontinuing, dissolution, diverse, dose, dramatically, emptying, engineered, equally, establishment, expediting, extension, extinguishing, family, fifteen, forecasted, Foundation, furnish, furnished, gained, gastric, generation, genetically, gland, Glaxo, Goldberg, group, heart, hospital, host, humanization, immunogenicity, implementation, impose, infect, installing, interfering, interrupting, Introduction, itching, ix, jacobson, largely, leader, Leon, likeliest, line, liquidate, liquidation, liter, living, load, Mallinckrodt, match, medication, melanoma, Memorial, mice, mitigate, monthly, mouse, multiplication, nausea, noncreditable, nonexclusive, nonrefundable, North, opening, optimize, original, overseeing, owner, parenteral, PDL, penetrate, physical, physician, pioneering, placebo, plasma, plc, practicable, produced, quickly, reach, recommended, recurrent, release, remedy, reorganization, replace, replacement, representation, resale, responded, restored, resume, retention, reversal, reversing, Roche, rolling, rsPSMA, sooner, specificity, stay, step, Stimulon, stool, supplemented, surgically, survival, suspended, tolerated, trauma, UC, undergo, undetectable, undetectably, unexpired, urinary, valid, version, vii, viii, vivo, vomiting, Western, yielding
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Exhibit 23.1 Consent of Pricewaterhousecoopers
- 31.1 Exhibit 31.1 Certification
- 31.2 Exhibit 31.2 Certification
- 32.1 Exhibit 32.1 Certification
- 32.2 Exhibit 32.2 Certification
- 10.29 Exhibit 10.29 Ono-progenics Collaboration
- 10.32 Exhibit 10.32 Chicago Agreement
- 10.31 Exhibit 10.31 Wyeth Consent
- 10.30 Exhibit 10.30 Partial Termination and License Agreement
Related press release
PGNX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-130913, 333-130912) and Form S-8 (Nos. 333-124910, 333-120508, 333-119463, 333-56571, 333-52277, 333-143671, 333-143670, 333-151711) of Progenics Pharmaceuticals, Inc. of our report dated March 9, 2009 relating to the financial statements, and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP | |
New York, New York | |
March 9, 2009 |